KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Receivables: 2017-2025

Historic Change in Receivables for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $22.4 million.

  • Twist Bioscience's Change in Receivables rose 144.08% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 365.06%. This contributed to the annual value of $22.4 million for FY2025, which is 365.06% up from last year.
  • Latest data reveals that Twist Bioscience reported Change in Receivables of $22.4 million as of FY2025, which was up 365.06% from -$8.4 million recorded in FY2024.
  • Twist Bioscience's Change in Receivables' 5-year high stood at $22.4 million during FY2025, with a 5-year trough of -$8.4 million in FY2024.
  • Over the past 3 years, Twist Bioscience's median Change in Receivables value was $4.3 million (recorded in 2023), while the average stood at $6.1 million.
  • As far as peak fluctuations go, Twist Bioscience's Change in Receivables crashed by 295.46% in 2024, and later surged by 365.06% in 2025.
  • Over the past 5 years, Twist Bioscience's Change in Receivables (Yearly) stood at $2.2 million in 2021, then spiked by 336.97% to $9.6 million in 2022, then tumbled by 55.10% to $4.3 million in 2023, then tumbled by 295.46% to -$8.4 million in 2024, then skyrocketed by 365.06% to $22.4 million in 2025.